Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Diagnostics » HME-5830617
  • Global Veterinary Diagnostics Market- Technologies, Market share and Industry Forecast to 2024

  • Publish: June 2017 | Report Code: HME-5830617

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Veterinary imaging helps to diagnose chronic diseases by obtaining medical images of animal bodies. Due to the increasing concern for the health of pet animals, many technologies have been evolved over the years, amongst which veterinary imaging is the new trend. Diagnosis of imaging instruments from human medicine is the base for the evolution of this technique, note that it is also a non-invasive method. Detection of sinus/nasal diseases is done through differentiating the neoplasia from rhinitis, following this the biopsy test results are guided. These instruments apart from imaging, offer various services such as they are capable in detecting brain hemorrhage and skull fractures. Similarly, visualization of brain tumors (most types) is also done through this technique. This method is simple and reliable as it eliminates the use of darkroom, film, film jackets, photo processing supplies etc. This in turn prove to be cost effective. The market of veterinary imaging technology is expected to rise by 6% during the period considered for analysis.

Increasing concern for the health of pet animals, along with it, rising expenditure on animal healthcare are the major drivers of this market. Apart from these, growing companion animals market, rise in demand for animal derived food products are also driving the veterinary imaging market. Followed by the trend, innovations and modifications in veterinary imaging instruments is turning out to be a driver in the growth of veterinary imaging market.

Source: OBRC analysis

 

The global veterinary imaging market is broadly classified into products, animal type, therapeutic Area and end user.

Products are further segmented as:

  • Instruments 
  • Veterinary Imaging Reagents 
  • Veterinary Software




There are sub segments of animal type also:

  • Small Companion Animals 
  • Large Animals
  • Other Animals




The third segment which is the therapeutic area has been further bifurcated into:

  • Orthopedics and Traumatology 
  • Oncology 
  • Cardiology 
  • Neurology 
  • Other Therapeutic Areas






The last segment (end user) has the following sub segments:

  • Clinics 
  • Hospitals & Academic Institutions



The Global veterinary imagimg market has been geographically segmented into:

  • North America (US & Canada)
  • Asia Pacific (China, India, Japan, Australia, Rest of Asia Pacific)
  • Europe (UK, France, Germany, Rest of Europe)
  • Rest of the World (RoW)





Thus, the veterinary imaging market has products, animal type, therapeutic area and end user as its sub segments. The product segment is further divided into instruments, veterinary imaging reagents and veterinary software. Instruments are again divided into radiography (X-ray) systems, ultrasound imaging systems, computed tomography imaging systems, video endoscopy imaging systems, magnetic resonance imaging systems and other imaging systems. In 2016, the largest share has been held by the radiography segment in global veterinary imaging instruments market. Cost effectiveness, increasing preference (by veterinarians) and high quality images provided by X-ray are the reasons which lead to hold the largest market share. On the basis of animal type, the sub segments are small companion animals, large animals and other animals. The third segment “therapeutic area” has been again segmented into orthopedics and traumatology, oncology, cardiology, neurology and other therapeutic areas. Orthopedics & traumatology segment is accounted at the peak in terms of market share (2016) for global veterinary imaging market. Increasing accidents (bone injuries), lameness disease and surging prevalence of arthritis in animals are the reasons which are responsible for making it leading segment. The end user has clinics and hospitals & academic institutions as its sub segments.

The veterinary imaging market has its roots spread all across the globe. North America is leading the global veterinary market due to well established economy and increasing concept of pet animal insurance. Rising expenditure in animal healthcare is also helping North America to stay on the top in the market of veterinary imaging technology. Rising number of veterinary practitioners is spreading the awareness of pet animal health insurance and this in turn is also promoting the veterinary imaging market. Rise in the income level of veterinary practitioners is also increasing the market share of North America in this market. While, Asia Pacific is expected to rise with the highest CAGR during the forecast period. Surging pet adoption, increasing concern in animal health-care and growth in per capita animal health expenditure in China and India are the major drivers which are promising the growth of this market in Asia Pacific.

Some of the leading market players within global veterinary imaging market are:

  • GE Healthcare
  • Agfa-Gevaert 
  • Hallmarq Veterinary Imaging Ltd.
  • Diagnostic Imaging Systems, Inc. 
  • Fujifilm Holdings Corporation
  • Others







Merger & acquisition, partnership, collaboration and product launch are some of the strategies used by companies within global veterinary imaging market. Of these, collaboration, and merger & acquisition are primary strategies adopted by companies for increasing their market share. For example, on 26th July, 2017, E.I. Medical Imaging (EIMI) has announced the partnership with Dr. Tristan Guttridge and the Bimini SharkLab to design first ultrasound system of the world. This system is to be used underwater for producing diagnostic images of sharks in their native habitat. Another example is: On 27th July, 2017, MedVet Medical & Cancer Centers for Pets has entered into a partnership with Animal Emergency Clinic Northeast (AECNE) and Animal Emergency Clinic West (AECW). As a result of this partnership, these organizations are named as MedVet Cleveland Northeast and MedVet Cleveland West. Local veterinarians will have continued support in managing the diagnosis of pets in the greater Cleveland due to these partnerships.  

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in the global veterinary imaging market.

Key reasons to buy the report:

  • The report include market estimation forecast and analysis for the year 2016-2023.
  • The report points out scenarios that can drive, challenge, and restraint global veterinary imaging market.
  • Company profiling within the report offers strategic initiatives, and market share analysis of major players within the market.
  • The report offers snapshot on recent regulatory and government policies impacting market growth for the forecasted period.





How we are different from others:

At OBRC, our reports offer an extensive portfolio through completed market analysis along with market share, market size, and market segmentation. The DROC’s for the markets are well thought out and researched after consulting with industry experts. Global veterinary imaging market showcases market analysis through models like investment vs adoption, see saw analysis, and so on. The report also provides overview on product application, adoption and decision support within each segment. The company profiling for each major players within the market is showcased via SCOT analysis.

Key findings of the global veterinary imaging market:

  • North America and Europe dominate veterinary imaging market in terms of revenue and technology adoption.
  • Asia Pacific is promising to register the highest CAGR during the forecast period as India and China are marching towards growing animal healthcare expenditure.
  • Clinics segment is adopting veterinary imaging technique at a rapid rate and contributing towards the market revenue.
  • Innovations in veterinary imaging instruments is driving the global veterinary market and having a considerable share in the market revenue.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL VETERINARY DIAGNOSTICS MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INCREASING CONSUMER SPENDING ON PETS
3.1.2. INCREASING LIVESTOCK POPULATION
3.1.3. INCREASING PREVALENCE OF ANIMAL DISEASES ACROSS THE GLOBE
3.1.4. INNOVATION IN VETERINARY DIAGNOSTICS 
3.1.5. INCREASING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS
3.2. MARKET RESTRAINTS
3.2.1. SCARCITY OF ARABLE LAND AND WATER
3.2.2. HIGH COST ASSOCIATED WITH VETERINARY DIAGNOSTIC TESTS
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING DEMAND FOR PET INSURANCE
3.3.2. INCREASING AWARENESS REGARDING ANIMAL HEALTH IN DEVELOPING COUNTRIES
3.4.   MARKET CHALLENGES 
3.4.1. LACK OF VETERINARIANS IN DEVELOPING COUNTRIES
3.4.2. INCREASING TREND TOWARDS VEGETARIAN DIET
4. MARKET SEGMENTATION 
4.1. GLOBAL VETERINARY DIAGNOSTICS MARKET BY TECHNOLOGY
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL IMMUNODIAGNOSTIC TESTS MARKET 
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.1.5. SUB-SEGMENTS
4.1.5.1.5.1. Allergen-Specific Immunodiagnostic Tests
4.1.5.1.5.2. Elisa Tests
4.1.5.1.5.3. Immunoassay Analyzers
4.1.5.1.5.4. Lateral Flow Assays
4.1.5.1.5.5. Others
4.1.5.2. GLOBAL MOLECULAR DIAGNOSTICS MARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.2.5. SUB-SEGMENTS
4.1.5.2.5.1. POLYMERASE CHAIN REACTION (PCR)
4.1.5.2.5.2. MICROARRAYS
4.1.5.2.5.3. OTHERS
4.1.5.3. GLOBAL DIAGNOSTIC IMAGING MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.3.5. SUB-SEGMENTS
4.1.5.3.5.1. MRI SCANNING
4.1.5.3.5.2. ULTRASOUND IMAGING
4.1.5.3.5.3. OTHERS
4.1.5.4. GLOBAL HEMATOLOGY ANALYZERS MARKET
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.4.4. KEY CONCLUSIONS
4.1.5.5. GLOBAL CLINICAL BioCHEMISTRY MARKET
4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.5.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.5.4. KEY CONCLUSIONS
4.1.5.6. GLOBAL OTHER TECHNOLOGIES MARKET
4.1.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.6.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.6.4. KEY CONCLUSIONS
4.2. GLOBAL VETERINARY DIAGNOSTICS MARKET BY PRODUCT 
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL VETERINARY DIAGNOSTICS CONSUMABLES  MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL VETERINARY DIAGNOSTICS INSTRUMENTS MARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.4. KEY CONCLUSIONS
4.3. GLOBAL VETERINARY DIAGNOSTICS MARKET BY ANIMAL TYPE
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL COMPANION ANIMALS  MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.1.5. SUB-SEGMENTS
4.3.5.1.5.1. CATS
4.3.5.1.5.2. DOGS
4.3.5.1.5.3. HORSE
4.3.5.1.5.4. Others
4.3.5.2. GLOBAL Livestock ANIMALS MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.2.5. SUB-SEGMENTS
4.3.5.2.5.1. CATTLE
4.3.5.2.5.2. POULTRY
4.3.5.2.5.3. SWINE
4.3.5.2.5.4. Others
4.4. GLOBAL VETERINARY DIAGNOSTICS MARKET BY APPLICATION
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL VETERINARY DIAGNOSTICS MARKET IN REFERENCE LABORATORIES
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL VETERINARY DIAGNOSTICS MARKET IN VETERINARY HOSPITALS & CLINICS
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL VETERINARY DIAGNOSTICS MARKET IN POINT-OF-CARE/IN-HOUSE TESTING
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.3.4. KEY CONCLUSIONS
4.4.5.4. GLOBAL VETERINARY DIAGNOSTICS MARKET IN RESEARCH INSTITUTIONS & UNIVERSITIES
4.4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.4.4. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITIONS
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL VETERINARY DIAGNOSTICS MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. ABAXIS, INC. (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. ABBOTT LABORATORIES (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.2.5. STRATEGIC ANALYSIS
7.3. ACON LABORATORIES, INC. (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS 
7.3.5. STRATEGIC ANALYSIS
7.4. BIO-RAD LABORATORIES, INC. (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. HENRY SCHEIN, INC. (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. HESKA CORPORATION (U.S.)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.7. HORIBA, LTD. (JAPAN)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.8. ID VET (FRANCE)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. IDEXX LABORATORIES, INC. (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. MINDRAY MEDICAL INTERNATIONAL LTD. (CHINA)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS 
7.10.5. STRATEGIC ANALYSIS
7.11. NEOGEN CORP. (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS 
7.11.5. STRATEGIC ANALYSIS
7.12. PFIZER, INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS 
7.12.5. STRATEGIC ANALYSIS
7.13. QIAGEN NV (GERMANY)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. THERMO FISHER SCIENTIFIC, INC. (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. ZOETIS, INC. (U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
LIST OF TABLES
1. GLOBAL VETERINARY DIAGNOSTICS MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
2. GLOBAL IMMUNODIAGNOSTIC TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL DIAGNOSTIC IMAGING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL HEMATOLOGY ANALYZERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL CLINICAL CHEMISTRY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL OTHER TECHNOLOGIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL VETERINARY DIAGNOSTICS MARKET BY PRODUCT 2014-2023 ($ MILLION)
9. GLOBAL VETERINARY DIAGNOSTICS CONSUMABLES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL VETERINARY DIAGNOSTICS INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL VETERINARY DIAGNOSTICS MARKET BY ANIMAL TYPE 2014-2023 ($ MILLION)
12. GLOBAL COMPANION ANIMALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL FARM ANIMALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL VETERINARY DIAGNOSTICS MARKET BY APPLICATION 2014-2023 ($ MILLION)
15. GLOBAL VETERINARY DIAGNOSTICS MARKET IN REFERENCE LABORATORIES 2014-2023 ($ MILLION)
16. GLOBAL VETERINARY DIAGNOSTICS MARKET IN VETERINARY HOSPITALS & CLINICS 2014-2023 ($ MILLION)
17. GLOBAL VETERINARY DIAGNOSTICS MARKET IN POINT-OF-CARE/IN-HOUSE TESTING 2014-2023 ($ MILLION)
18. GLOBAL VETERINARY DIAGNOSTICS MARKET IN RESEARCH INSTITUES & UNIVERSITIES 2014-2023 ($ MILLION)
19. NORTH AMERICA VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
20. EUROPE VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
21. ASIA PACIFIC VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
22. REST OF THE WORLD VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
1. GLOBAL VETERINARY DIAGNOSTICSMARKET BY IMMUNODIAGNOSTIC TESTS 2014-2023 ($ MILLION)
2. GLOBAL VETERINARY DIAGNOSTICS MARKET BY ENZYME LINKED IMMUNO-SORBENT ASSAY (ELISA) 2014-2023 ($ MILLION)
3. GLOBAL VETERINARY DIAGNOSTICS MARKET BY AGAR GEL IMMUNO-DIFFUSION (AGID) 2014-2023 ($ MILLION)
4. GLOBAL VETERINARY DIAGNOSTICS MARKET BY RAPID IMMUNO MIGRATION (RIM) 2014-2023 ($ MILLION)
5. GLOBAL VETERINARY DIAGNOSTICS MARKET BY OTHERS 2014-2023 ($ MILLION)
6. GLOBAL VETERINARY DIAGNOSTICS MARKET BY MOLECULAR DIAGNOSTICS  2014-2023 ($ MILLION)
7. GLOBAL VETERINARY DIAGNOSTICS MARKET BY POLYMERASE CHAIN REACTION (PCR) 2014-2023 ($ MILLION)
8. GLOBAL VETERINARY DIAGNOSTICS MARKET BY IN-SITU HYBRIDIZATION (ISH) 2014-2023 ($ MILLION)
9. GLOBAL VETERINARY DIAGNOSTICS MARKET BY MICROARRAYS 2014-2023 ($ MILLION)
10. GLOBAL VETERINARY DIAGNOSTICS MARKET BY SEQUENCING (DNA & NGS) 2014-2023 ($ MILLION)
11. GLOBAL VETERINARY DIAGNOSTICS MARKET BY OTHERS 2014-2023 ($ MILLION)
12. GLOBAL VETERINARY DIAGNOSTICS MARKET BY DIAGNOSTIC IMAGING 2014-2023 ($ MILLION)
13. GLOBAL VETERINARY DIAGNOSTICS MARKET BY MRI SCANNING 2014-2023 ($ MILLION)
14. GLOBAL VETERINARY DIAGNOSTICS MARKET BY ULTRASOUND IMAGING 2014-2023 ($ MILLION)
15. GLOBAL VETERINARY DIAGNOSTICS MARKET BY OTHERS 2014-2023 ($ MILLION)
16. GLOBAL VETERINARY DIAGNOSTICS MARKET BY HEMATOLOGY ANALYZERS 2014-2023 ($ MILLION)
17. GLOBAL VETERINARY DIAGNOSTICS MARKET BY MICROARRAYS 2014-2023 ($ MILLION)
18. GLOBAL VETERINARY DIAGNOSTICS MARKET BY SEQUENCING (DNA & NGS) 2014-2023 ($ MILLION)
19. GLOBAL VETERINARY DIAGNOSTICS MARKET BY OTHERS 2014-2023 ($ MILLION)
20. GLOBAL VETERINARY DIAGNOSTICS MARKET BY DIAGNOSTIC IMAGING 2014-2023 ($ MILLION)
21. GLOBAL VETERINARY DIAGNOSTICS MARKET BY MRI SCANNING 2014-2023 ($ MILLION)
22. GLOBAL VETERINARY DIAGNOSTICS MARKET BY ULTRASOUND IMAGING 2014-2023 ($ MILLION)
23. GLOBAL VETERINARY DIAGNOSTICS MARKET BY OTHERS 2014-2023 ($ MILLION)
24. GLOBAL VETERINARY DIAGNOSTICS MARKET BY HEMATOLOGY ANALYZERS 2014-2023 ($ MILLION)
25. GLOBAL VETERINARY DIAGNOSTICS MARKET BY CLINICAL CHEMISTRY 2014-2023 ($ MILLION)
26. GLOBAL VETERINARY DIAGNOSTICS MARKET BY OTHER TECHNOLOGIES 2014-2023 ($ MILLION)
27. GLOBAL VETERINARY DIAGNOSTICS MARKET BY CONSUMABLES 2014-2023 ($ MILLION)
28. GLOBAL VETERINARY DIAGNOSTICS MARKET BY INSTRUMENTS 2014-2023 ($ MILLION)
29. GLOBAL VETERINARY DIAGNOSTICS MARKET BY COMPANION ANIMALS 2014-2023 ($ MILLION)
30. GLOBAL VETERINARY DIAGNOSTICS MARKET BY CATS 2014-2023 ($ MILLION)
31. GLOBAL VETERINARY DIAGNOSTICS MARKET BY HORSE 2014-2023 ($ MILLION)
32. GLOBAL VETERINARY DIAGNOSTICS MARKET BY DOGS 2014-2023 ($ MILLION)
33. GLOBAL VETERINARY DIAGNOSTICS MARKET BY FARM ANIMALS 2014-2023 ($ MILLION)
34. GLOBAL VETERINARY DIAGNOSTICS MARKET BY POULTRY 2014-2023 ($ MILLION)
35. GLOBAL VETERINARY DIAGNOSTICS MARKET BY FISH 2014-2023 ($ MILLION)
36. GLOBAL VETERINARY DIAGNOSTICS MARKET BY CATTLE 2014-2023 ($ MILLION)
37. GLOBAL VETERINARY DIAGNOSTICS MARKET BY SWINE 2014-2023 ($ MILLION)
38. GLOBAL VETERINARY DIAGNOSTICS MARKET BY SHEEP 2014-2023 ($ MILLION)
39. GLOBAL VETERINARY DIAGNOSTICS MARKET BY REFERENCE LABORATORIES 2014-2023 ($ MILLION)
40. GLOBAL VETERINARY DIAGNOSTICS MARKET BY VETERINARY HOSPITALS & CLINICS 2014-2023 ($ MILLION)
41. GLOBAL VETERINARY DIAGNOSTICS MARKET BY IN POINT-OF-CARE/IN-HOUSE TESTING 2014-2023 ($ MILLION)
42. GLOBAL VETERINARY DIAGNOSTICS MARKET IN RESEARCH INSTITUTIONS & UNIVERSITIES 2014-2023 ($ MILLION)
43. UNITED STATES (U.S.) VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
44. CANADA VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
45. UNITED KINGDOM (UK) VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
46. FRANCE VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
47. GERMANY VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
48. SPAIN VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
49. ROE VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
50. INDIA VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
51. CHINA VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
52. JAPAN VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
53. AUSTRALIA VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
54. ROAPAC VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
55. LATIN AMERICA VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
56. MENA VETERINARY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion